Open Access

[Retracted] Epidermal growth factor-stimulated human cervical cancer cell growth is associated with EGFR and cyclin D1 activation, independent of COX-2 expression levels

  • Authors:
    • Rajkishen Narayanan
    • Hye Na Kim
    • Narayanan K. Narayanan
    • Dominick Nargi
    • Bhagavathi Narayanan
  • View Affiliations

  • Published online on: October 18, 2016     https://doi.org/10.3892/ijo.2016.3737
  • Pages: 337-337
  • Copyright: © Narayanan et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

January-2017
Volume 50 Issue 1

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Narayanan R, Kim HN, Narayanan NK, Nargi D and Narayanan B: [Retracted] Epidermal growth factor-stimulated human cervical cancer cell growth is associated with EGFR and cyclin D1 activation, independent of COX-2 expression levels. Int J Oncol 50: 337-337, 2017
APA
Narayanan, R., Kim, H.N., Narayanan, N.K., Nargi, D., & Narayanan, B. (2017). [Retracted] Epidermal growth factor-stimulated human cervical cancer cell growth is associated with EGFR and cyclin D1 activation, independent of COX-2 expression levels. International Journal of Oncology, 50, 337-337. https://doi.org/10.3892/ijo.2016.3737
MLA
Narayanan, R., Kim, H. N., Narayanan, N. K., Nargi, D., Narayanan, B."[Retracted] Epidermal growth factor-stimulated human cervical cancer cell growth is associated with EGFR and cyclin D1 activation, independent of COX-2 expression levels". International Journal of Oncology 50.1 (2017): 337-337.
Chicago
Narayanan, R., Kim, H. N., Narayanan, N. K., Nargi, D., Narayanan, B."[Retracted] Epidermal growth factor-stimulated human cervical cancer cell growth is associated with EGFR and cyclin D1 activation, independent of COX-2 expression levels". International Journal of Oncology 50, no. 1 (2017): 337-337. https://doi.org/10.3892/ijo.2016.3737